Approval · Notice of Compliance 18090 · 2016
RAN-FENOFIBRATE E: Notice of Compliance 18090
Issued May 12, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18090
- Date
- May 12, 2016
- Company
- Ranbaxy Pharmaceuticals Canada Inc.Brampton, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Canadian reference product
- LIPIDIL EZ (Fournier Pharma Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAN-FENOFIBRATE E | 02454696 | Marketed |
Medicinal ingredients
- FENOFIBRATE 145 MG per TAB